365 related articles for article (PubMed ID: 16550716)
1. Markers of bone turnover: biochemical and clinical perspectives.
Pagani F; Francucci CM; Moro L
J Endocrinol Invest; 2005; 28(10 Suppl):8-13. PubMed ID: 16550716
[TBL] [Abstract][Full Text] [Related]
2. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females.
Weaver CM; Peacock M; Martin BR; McCabe GP; Zhao J; Smith DL; Wastney ME
J Bone Miner Res; 1997 Oct; 12(10):1714-20. PubMed ID: 9333133
[TBL] [Abstract][Full Text] [Related]
3. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
4. Role of biochemical markers of bone remodeling in clinical practice.
Camozzi V; Tossi A; Simoni E; Pagani F; Francucci CM; Moro L
J Endocrinol Invest; 2007; 30(6 Suppl):13-7. PubMed ID: 17721068
[TBL] [Abstract][Full Text] [Related]
5. Biochemical markers of bone turnover: an update.
van Daele PL; Birkenhäger JC; Pols HA
Neth J Med; 1994 Feb; 44(2):65-72. PubMed ID: 8208326
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
[TBL] [Abstract][Full Text] [Related]
7. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
[TBL] [Abstract][Full Text] [Related]
8. Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
Hannon R; Blumsohn A; Naylor K; Eastell R
J Bone Miner Res; 1998 Jul; 13(7):1124-33. PubMed ID: 9661076
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of biochemical marker of bone remodelling in patients with bone metastases of solid tumors.
Seregni E; Martinetti A; Ferrari L; Bombardieri E
Q J Nucl Med; 2001 Mar; 45(1):7-17. PubMed ID: 11456378
[TBL] [Abstract][Full Text] [Related]
10. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
[TBL] [Abstract][Full Text] [Related]
11. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
12. New and traditional serum markers of bone metabolism in the detection of skeletal metastases.
Plebani M; Bernardi D; Zaninotto M; De Paoli M; Secchiero S; Sciacovelli L
Clin Biochem; 1996 Feb; 29(1):67-72. PubMed ID: 8929827
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers of bone turnover: biochemical, technical and analytical aspects.
Seibel MJ
Osteoporos Int; 2000; 11 Suppl 6():S18-29. PubMed ID: 11193236
[No Abstract] [Full Text] [Related]
14. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
[TBL] [Abstract][Full Text] [Related]
15. Biological variation in bone-derived biochemical markers in serum.
Panteghini M; Pagani F
Scand J Clin Lab Invest; 1995 Nov; 55(7):609-16. PubMed ID: 8633185
[TBL] [Abstract][Full Text] [Related]
16. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
Rissanen JP; Suominen MI; Peng Z; Halleen JM
Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
[TBL] [Abstract][Full Text] [Related]
17. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of bone turnover in girls during puberty.
Blumsohn A; Hannon RA; Wrate R; Barton J; al-Dehaimi AW; Colwell A; Eastell R
Clin Endocrinol (Oxf); 1994 May; 40(5):663-70. PubMed ID: 7516828
[TBL] [Abstract][Full Text] [Related]
19. Circulating biochemical markers of bone remodeling in uremic patients.
Ureña P; De Vernejoul MC
Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
[TBL] [Abstract][Full Text] [Related]
20. Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover.
Nenonen A; Cheng S; Ivaska KK; Alatalo SL; Lehtimäki T; Schmidt-Gayk H; Uusi-Rasi K; Heinonen A; Kannus P; Sievänen H; Vuori I; Väänänen HK; Halleen JM
J Bone Miner Res; 2005 Oct; 20(10):1804-12. PubMed ID: 16355501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
